Company Encyclopedia
View More
name
Thermo Fisher Scentific
TMO.US
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
770.89 B
TMO.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking14/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE13.14%B
    • Profit Margin15.02%A
    • Gross Margin41.30%B
  • Growth ScoreC
    • Revenue YoY3.22%C
    • Net Profit YoY7.09%C
    • Total Assets YoY2.65%C
    • Net Assets YoY4.19%C
  • Cash ScoreC
    • Cash Flow Margin665.69%C
    • OCF YoY3.22%C
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreC
    • Gearing Ratio50.35%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Michel Lagarde, Executive Vice President & COO, reports disposal of Thermo Fisher Scientific Inc. common shares

    Michel Lagarde, Executive Vice President & COO of Thermo Fisher Scientific Inc., has reported the disposal of common shares of the company. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 4, 2025. This brief was generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    TMO
    -0.90%
    Reuters·
    US
    TMO
    -0.90%

    Thermo Fisher Scientific (TMO): Reassessing Valuation After Recent Share Price Gains

    Thermo Fisher Scientific's shares have risen 3% in the past month, prompting a valuation reassessment. Despite trading below analyst targets, the stock shows strong growth potential, driven by innovation in genomics and precision medicine. The fair value is estimated at $613.58, indicating it is undervalued. However, risks include China's economic weakness and funding pressures. The current P/E ratio is 33.2, slightly above the fair ratio of 30.9. Investors are encouraged to explore other healthcare stocks and consider potential mispricings.

    Simplywall·
    US
    TMO
    -0.90%
    Simplywall·
    US
    TMO
    -0.90%

    Genincode Collaborates With Thermo Fisher

    Genincode PLC :GENINCODE PLC - COLLABORATION WITH THERMO FISHERGENINCODE PLC - ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFICGENINCODE PLC - COLLABORATION INCLUDES MANUFACTURING AND DISTRIBUTION OF CARDIO INCODE-SCORE ACROSS US AND EMEA

    Reuters·
    US
    TMO
    -0.90%
    Reuters·
    US
    TMO
    -0.90%

    VP Shropshire Jr Surrenders 337 Of Thermo Fisher Scientific Inc [TMO]

    VP Shropshire Jr of Thermo Fisher Scientific Inc surrendered 337 shares to cover option exercise costs and tax liabilities, as disclosed in a Form 4 filed with the SEC on December 3, 2025. The transaction was valued at $195,861, with an ending holding of 5,080 shares.

    Reuters·
    US
    TMO
    -0.90%
    Reuters·
    US
    TMO
    -0.90%

    Thermo Fisher Executive Vice President Frederick M. Lowery Reports Sale of Common Shares

    Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific Inc., reported the sale of common shares of the company. The original filing is available via EDGAR, the SEC's system. This news brief was generated by Public Technologies using AI and is not financial advice.

    Reuters·
    US
    TMO
    -0.90%
    Reuters·
    US
    TMO
    -0.90%
    © 2025 Longbridge｜Disclaimer